[1]
Agarwal, T., Annamalai, N., Ronanki, H.P., Butty, S., Maiti, T.K. and Arsad, H.B. 2018. MUTANT P21 PEPTIDES COULD ACT AS AN IMPROVED CYCLIN A INHIBITORS FOR CANCER THERAPY: AN IN SILICO VALIDATION. International Journal of Pharmacy and Pharmaceutical Sciences. 11, 2 (Dec. 2018), 59-64. DOI:https://doi.org/10.22159/ijpps.2019v11i2.30577.